Background Heart failure (HF) remains a major and growing public health burden, affecting over 6 million adults in the United States, with prevalence projected to increase substantially in the coming decade
With respect to the prescription of semaglutide for ensuring weight management, Health Canada has given approval to the 2.4 mg of injection to serve as a measure to be implemented in addition to a reduced calorie diet and increased activity to manage weight in patients having: A BMI of 30 kg/m2 or higher (obesity) A BMI of 27 kg/m2 or higher (overweight) In addition to this, it is also expected that the patient should suffer from chronic weight-related issues, like dyslipidemia, hypertension, or obstructive sleep apnea
When youre resting enough, it can help your body acclimate to the medication more effectively
containing more whole foods vs
It should always be used as part of a medically-overseen plan, and supports steady progress when used alongside healthy lifestyle changes